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FUNGAL DESATURASES AND RELATED 
METHODS 
TECHNICAL FIELD 
The presently-disclosed subject matter relates to fungal 
desaturases and methods of using the same. In particular, the 
presently-disclosed subject matter relates to novel nucleotide 
and amino acid sequences for mushroom desaturases and 
methods of using these sequences to produce monounsat 
urated fatty acids. 
BACKGROUND 
Plants naturally produce an assortment of fatty acids and 
synthesiZe a Wide assortment of lipids, including mono-, di-, 
and tri-acylglycerols, phospholipids, glycolipids, and others, 
from the fatty acids produced by the plants. The speci?c 
assortment of lipids made by any particular plant is deter 
mined by both the genotype of the plant and the plant’s 
response to environmental factors such as heat, cold, and 
drought. HoWever, regardless of the environmental condi 
tions a plant is faced With, a plant can never produce a fatty 
acid or lipid composition for Which it does not have the 
necessary biochemical machinery. 
Recently, there has been an increasing interest in reducing 
the content of saturated fatty acids in food for diet and health 
purposes. Medical and nutritional research continues to indi 
cate that unsaturated fatty acids, such as those found in oil 
seed plants, are important components of diets for a variety of 
reasons. For example, certain monounsaturated fatty acids, 
such as palmitoleic acid, have been implicated in loWering the 
risk of cardiovascular and cerebrovascular diseases, in the 
regulation of immuno functions, and in the attenuation of 
in?ammations. Efforts have therefore been initiated to 
develop oilseed varieties and plants Which yield oils With 
higher monounsaturated fatty acid contents. HoWever, the 
traditional methods of genetic modi?cation of plants have 
involved recombination processes Which are typically 
directed by the plant breeder at a Whole plant level, and only 
produce incremental improvements in oil content and com 
position by optimiZing the native biochemistry of a particular 
plant species, rather than considerably augmenting or intro 
ducing a biochemical pathWay. 
Further, even When traditional plant breeding methods are 
successful in altering the fatty acid composition of a particu 
lar plant variety, the native biochemical pathWays of a plant 
Will still generally exhibit all of their traditional characteris 
tics and limitations. For example, the fatty acid compositions 
of many oilseed crops have been improved by plant breeding 
to include a higher content of unsaturated fatty acids. HoW 
ever, these oilseed crops continue to exhibit the usual 
response to environmental conditions such as a tendency to 
produce a higher percentage of saturated fatty acids under 
Warmer groWing conditions and a higher percentage of unsat 
urated fatty acids under cooler groWing conditions, thus mak 
ing the reliable production of oilseeds having a particular 
fatty acid composition difficult. 
Accordingly, there remains a need in the art for composi 
tions and methods useful for producing monounsaturated 
fatty acids. 
SUMMARY 
The presently-disclosed subject matter meets some or all of 
the above-identi?ed needs, as Will become evident to those of 
ordinary skill in the art after a study of information provided 
in this document. 
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This Summary describes several embodiments of the pres 
ently-disclosed subject matter, and in many cases lists varia 
tions and permutations of these embodiments. This Summary 
is merely exemplary of the numerous and varied embodi 
ments. Mention of one or more representative features of a 
given embodiment is likeWise exemplary. Such an embodi 
ment can typically exist With or Without the feature(s) men 
tioned; likeWise, those features can be applied to other 
embodiments of the presently-disclosed subject matter, 
Whether listed in this Summary or not. To avoid excessive 
repetition, this Summary does not list or suggest all possible 
combinations of such features. 
In some embodiments of the presently-disclosed subject 
matter, isolated nucleic acid and amino acid sequences are 
provided that encode a fungal desaturase polypeptide. In 
some embodiments, an isolated nucleic acid is provided that 
comprises a sequence that encodes a mushroom desaturase 
polypeptide or a functional fragment or functional variant 
thereof, Where the mushroom desaturase is active With both 
palmitic acid and stearic acid. In some embodiments, the 
isolated nucleic acid comprises the sequence of SEQ ID NO: 
1 or the sequence of SEQ ID NO: 2, or degenerate variants 
thereof. In some embodiments, the isolated nucleic acid 
encodes an amino acid sequence of SEQ ID NO: 3 or SEQ ID 
NO: 4, or functional fragments or functional variants thereof. 
In some embodiments of the presently-disclosed subject 
matter, an isolated polypeptide is provided that comprises a 
mushroom desaturase polypeptide, or a functional fragment 
or functional variant thereof, that is active With both palmitic 
acid and stearic acid. In some embodiments, the polypeptide 
is isolated from R oslrealus. In some embodiments, the 
polypeptide is a P oslrealus A9 desaturase polypeptide. In 
some embodiments, the polypeptide has an amino acid 
sequence of SEQ ID NO: 3 or SEQ ID NO: 4, or functional 
fragments or functional variants thereof. In some embodi 
ments, the polypeptide is encoded by a nucleic acid com 
prised of the sequence of SEQ ID NO: 1 or the sequence of 
SEQ ID NO: 2, or fragments thereof that are capable of 
encoding a functional fragment or functional variant of the 
polypeptide. 
Further provided are vectors that comprise a nucleic acid of 
the presently-disclosed subject matter. In some embodi 
ments, a vector is provided that comprises a nucleic acid 
comprising a sequence that encodes a mushroom desaturase. 
In some embodiments, the nucleic acid sequences can be 
operably linked to an expression cassette that can further 
include seed-speci?c or constitutive promoters. 
In some embodiments of the presently-disclosed subject 
matter, transgenic plant cells are provided. In some embodi 
ments, the transgenic plant cell is comprised of a nucleic acid 
of the presently-disclosed subject matter that encodes a 
mushroom desaturase polypeptide or a functional fragment or 
functional variant thereof. In some embodiments, the trans 
genic plant cell can be an Arabidopsis plant cell, a tobacco 
plant cell, a soybean plant cell, a petunia plant cell, a canola 
plant cell, a rapeseed plant cell, a palm plant cell, a sun?ower 
plant cell, a cotton plant cell, a corn plant cell, a peanut plant 
cell, a ?ax plant cell, and a sesame plant cell. 
The presently-disclosed subject matter further provides a 
method of producing a monounsaturated fatty acid. In some 
embodiments, the method comprises: transforming a cell 
With a nucleic acid of the presently-disclosed subject matter 
that encodes a mushroom desaturase polypeptide, or a func 
tional fragment or a functional variant thereof, that is active 
With palmitic acid and stearic acid; expressing the desaturase 
polypeptide to increase an amount of the monounsaturated 
fatty acid in the cell; and, extracting an oil containing the 
increased amount of the monounsaturated fatty acid from the 
cell. In some embodiments, the monounsaturated fatty acid 
can be palmitoleic acid or oleic acid. 
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Still further provided are monounsaturated fatty acids that 
are prepared by the presently-disclosed methods. In some 
embodiments, the monounsaturated fatty acids are prepared 
by a process that comprises: transforming a cell With a nucleic 
acid of the presently-disclosed subject matter that encodes a 
fungal desaturase polypeptide, or a functional fragment or a 
functional variant thereof, that is active With palmitic acid and 
stearic acid; expressing the desaturase polypeptide to 
increase an amount of the monounsaturated fatty acid in the 
cell; and, extracting an oil containing the increased amount of 
the monounsaturated fatty acid from the cell. 
Advantages of the presently-disclosed subject matter Will 
become evident to those of ordinary skill in the art after a 
study of the description, Figures, and non-limiting Examples 
in this document. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a picture depicting the southern hybridization of 
R oslrealus genomic DNA probed With a 550 bp A9 desatu 
rase speci?c PCR fragment. Depending on the restriction 
enZyme used to digest the genomic DNA, 1-4 strong bands 
are visible in the southern blot hybridization. 
FIG. 2 is a diagram depicting the desaturase and cyto 
chrome b5 portions of a R oslrealus A9 desaturase polypep 
tide. 
FIG. 3 is schematic diagram of a distance tree shoWing the 
homology of a R oslrealus A9 desaturase polypeptide With 
other fungal desaturase polypeptides. 
FIG. 4 is a chromatogram shoWing the results of a lipid 
analysis of a S. cerevisiae A9 desaturase mutant transformed 
With a R oslrealus A9 desaturase gene. 
FIG. 5 is a chart depicting a glycine 188 residue (under 
lined) that is conserved in both acyl-CoA and acyl-ACP 
desaturases (SEQ ID NOS: 32-50) from a variety of organ 
isms. 
FIG. 6 is a schematic diagram depicting the cloning of a R 
oslrealus A9 desaturase gene under the control of a phaseolin 
seed-speci?c promoter into a pCAMBIA 1301 plant transfor 
mation vector. 
FIG. 7 is a graph shoWing data from quantitative real time 
PCR of R oslrealus A9 desaturase mRNA levels in soybean 
transgenic lines Where the data are expressed as relative ?uo 
rescent units (RFU) versus PCR cycle. 
FIG. 8 is a graph shoWing data from quantitative real time 
PCR of yeast A9 desaturase mRNA levels in soybean trans 
genic lines Where the data are expressed as relative ?uores 
cent units (RFU) versus PCR cycle. 
FIGS. 9A and 9B shoW the alignment of a genomic nucleic 
acid sequence (Po gDNA; SEQ ID NO: 1) and a cDNA 
sequence (Po cDNA; SEQ ID NO: 2) of a R oslrealus A9 
desaturase gene. FIG. 9A includes nucleic acids 1 to 825 and 
FIG. 9B includes nucleic acids 826 to 1604 of the genomic 
nucleic acid sequence, Wherein the aligned nucleic acids of 
the cDNA sequence are presented immediately above the 
genomic nucleic acid sequence. Homology betWeen the tWo 
sequences is indicated by the highlighted areas. 
FIG. 10 includes an amino acid sequence of a full lengthR 
oslrealus A9 desaturase polypeptide (SEQ ID NO: 3), 
Wherein histidine residues corresponding to locations of his 
tidine box motifs are presented in bold. 
BRIEF DESCRIPTION OF THE SEQUENCE 
LISTING 
SEQ ID NO: 1 is a genomic nucleic acid sequence from R 
oslrealus. 
SEQ ID NO: 2 is a nucleic acid sequence of a cDNA 
obtained from R oslrealus. 
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SEQ ID NO: 3 is an amino acid sequence ofa full lengthR 
oslrealus A9 desaturase polypeptide. 
SEQ ID NO: 4 is an amino acid sequence of a desaturase 
portion of a R oslrealus A9 desaturase polypeptide. 
SEQ ID NO: 5 is an amino acid sequence of a homologous 
region of different fungal A9 desaturase proteins used to 
design a forWard primer for degenerate PCR. 
SEQ ID NO: 6 is an amino acid sequence of a homologous 
region of different fungal A9 desaturase proteins used to 
design a reverse primer for degenerate PCR. 
SEQ ID NO: 7 is a nucleic acid sequence of a forWard 
primer for degenerate PCR reactions used to amplify portions 
of a R oslrealus A9 desaturase gene. 
SEQ ID NO: 8 is a nucleic acid sequence of a forWard 
primer for degenerate PCR reactions used to amplify portions 
of a R oslrealus A9 desaturase gene. 
SEQ ID NO: 9 is a nucleic acid sequence of a forWard 
primer for degenerate PCR reactions used to amplify portions 
of a R oslrealus A9 desaturase gene. 
SEQ ID NO: 10 is a nucleic acid sequence of a reverse 
primer for degenerate PCR reactions used to amplify portions 
of a R oslrealus A9 desaturase gene. 
SEQ ID NO: 11 is a nucleic acid sequence of an inverse 
PCR primer for obtaining a 3' extension of a 500 bp product 
of a portion of a R oslrealus A9 desaturase gene. 
SEQ ID NO: 12 is a nucleic acid sequence of an inverse 
PCR primer for obtaining a 5' extension of a 500 bp product 
of a portion of a R oslrealus A9 desaturase gene. 
SEQ ID NO: 13 is a nucleic acid sequence of a forWard 
PCR primer for amplifying a R oslrealus A9 desaturase gene 
from R oslrealus genomic DNA and total RNA. 
SEQ ID NO: 14 is a nucleic acid sequence of a reverse PCR 
primer for amplifying a R oslrealus A9 desaturase gene from 
R oslrealus genomic DNA and total RNA. 
SEQ ID NO: 15 is a nucleic acid sequence of a forWard 
PCR primer for amplifying a S. cerevisiae A9 desaturase 
gene. 
SEQ ID NO: 16 is a nucleic acid sequence of a reverse PCR 
primer for amplifying a S. cerevisiae A9 desaturase gene. 
SEQ ID NO: 17 is a nucleic acid sequence of a forWard 
PCR primer for amplifying a S. cerevisiae URA3 gene from a 
pYES2 expression vector. 
SEQ ID NO: 18 is a nucleic acid sequence of a reverse PCR 
primer for amplifying a S. cerevisiae URA3 gene from a 
pYES2 expression vector. 
SEQ ID NO: 19 is a nucleic acid sequence of a forWard 
PCR primer for amplifying a construct comprised of a S. 
cerevisiae URA3 gene cloned into a pYES2 vector under a gal 
promoter. 
SEQ ID NO: 20 is a nucleic acid sequence of a reverse PCR 
primer for amplifying a construct comprised of a S. cerevisiae 
URA3 gene cloned into a pYES2 vector under a gal promoter. 
SEQ ID NO: 21 is a nucleic acid sequence of a forWard 
PCR primer for amplifying a S. cerevisiae A9 desaturase 
gene. 
SEQ ID NO: 22 is a nucleic acid sequence of a reverse PCR 
primer for amplifying a S. cerevisiae A9 desaturase gene. 
SEQ ID NO: 23 is a nucleic acid sequence of a forWard 
PCR primer for amplifying a R oslrealus A9 desaturase gene 
from a R oslrealus genomic clone. 
SEQ ID NO: 24 is a nucleic acid sequence of a reverse PCR 
primer for amplifying a R oslrealus A9 desaturase gene from 
a R oslrealus genomic clone. 
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SEQ ID NO: 25 is a nucleic acid sequence of a forward 
PCR primer for site directed mutagenesis of a R oslrealus A9 
desaturase gene. 
SEQ ID NO: 26 is a nucleic acid sequence of a reverse PCR 
primer for site directed mutagenesis of a P oslrealus A9 
desaturase gene. 
SEQ ID NO: 27 is a nucleic acid sequence of a forward 
PCR primer for site directed mutagenesis of a S. cerevisiae A9 
desaturase gene. 
SEQ ID NO: 28 is a nucleic acid sequence of a reverse PCR 
primer for site directed mutagenesis of a S. cerevisiae A9 
desaturase gene. 
SEQ ID NO: 29 is an amino acid sequence of a histidine 
box motif from a R oslrealus A9 desaturase polypeptide. 
SEQ ID NO: 30 is an amino acid sequence of a histidine 
box motif from a R oslrealus A9 desaturase polypeptide. 
SEQ ID NO: 31 is an amino acid sequence of a histidine 
box motif from a R oslrealus A9 desaturase polypeptide. 
SEQ ID NO: 32 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Ricinus communis. 
SEQ ID NO: 33 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Asclepias syriaca. 
SEQ ID NO: 34 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Brassica juncea. 
SEQ ID NO: 35 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Brassica napus. 
SEQ ID NO: 36 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Carlhamus Zinclorius. 
SEQ ID NO: 37 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Cucumis salivus. 
SEQ ID NO: 38 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Arachis hypogaea. 
SEQ ID NO: 39 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Elaeis guineensis. 
SEQ ID NO: 40 is an amino acid sequence of a fragment of 
a desaturase polypeptide of T hunbergia alala. 
SEQ ID NO: 41 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Homo sapiens. 
SEQ ID NO: 42 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Rallus norvegicus. 
SEQ ID NO: 43 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Caenorhabdilis elegans a. 
SEQ ID NO: 44 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Caenorhabdilis elegans b. 
SEQ ID NO: 45 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Caenorhabdilis elegans c. 
SEQ ID NO: 46 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Saccharomyces cerevisiae. 
SEQ ID NO: 47 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Pichia angusla. 
SEQ ID NO: 48 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Cryplococcus curvalus. 
SEQ ID NO: 49 is an amino acid sequence of a fragment of 
a desaturase polypeptide of Amylomyces rouxii. 
SEQ ID NO: 50 is an amino acid sequence of a fragment of 
a desaturase polypeptide of R oslrealus. 
DESCRIPTION OF EXEMPLARY 
EMBODIMENTS 
The details of one or more embodiments of the presently 
disclosed subject matter are set forth in this document. Modi 
?cations to embodiments described in this document, and 
other embodiments, Will be evident to those of ordinary skill 
in the art after a study of the information provided in this 
document. The information provided in this document, and 
particularly the speci?c details of the described exemplary 
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embodiments, is provided primarily for cleamess of under 
standing and no unnecessary limitations are to be understood 
therefrom. In case of con?ict, the speci?cation of this docu 
ment, including de?nitions, Will control. 
Some of the polynucleotide and polypeptide sequences 
disclosed herein are cross-referenced to GENBANK® acces 
sion numbers. The sequences cross-referenced in the GEN 
BANK® database are expressly incorporated by reference as 
are equivalent and related sequences present in GENBANK® 
or other public databases. Also expressly incorporated herein 
by reference are all annotations present in the GENBANK® 
database associated With the sequences disclosed herein. 
Unless otherWise indicated or apparent, the references to the 
GENBANK® database are references to the most recent ver 
sion of the database as of the ?ling date of this Application. 
While the terms used herein are believed to be Well under 
stood by one of ordinary skill in the art, de?nitions are set 
forth to facilitate explanation of the presently-disclosed sub 
ject matter. 
Unless de?ned otherWise, all technical and scienti?c terms 
used herein have the same meaning as commonly-understood 
by one of ordinary skill in the art to Which the presently 
disclosed subject matter belongs. Although any methods, 
devices, and materials similar or equivalent to those described 
herein can be used in the practice or testing of the presently 
disclosed subject matter, representative methods, devices, 
and materials are noW described. 
FolloWing long-standing patent laW convention, the terms 
“a”, “an”, and “the” refer to “one or more” When used in this 
application, including the claims. Thus, for example, refer 
ence to “a cell” includes a plurality of such cells, and so forth. 
Unless otherwise indicated, all numbers expressing quan 
tities of ingredients, properties such as reaction conditions, 
and so forth used in the speci?cation and claims are to be 
understood as being modi?ed in all instances by the term 
“about”. Accordingly, unless indicated to the contrary, the 
numerical parameters set forth in this speci?cation and claims 
are approximations that can vary depending upon the desired 
properties sought to be obtained by the presently-disclosed 
subject matter. 
As used herein, the term “about,” When referring to a value 
or to an amount of mass, Weight, time, volume, concentration 
or percentage is meant to encompass variations of in some 
embodiments 120%, in some embodiments 110%, in some 
embodiments 15%, in some embodiments 11%, in some 
embodiments 10.5%, and in some embodiments 10.1% from 
the speci?ed amount, as such variations are appropriate to 
perform the disclosed method. 
The term “fatty acid” is used herein to refer to long chain 
aliphatic acids of varying carbon chain lengths. Generally, the 
term “fatty acid” is used to describe fatty acids comprising 
about 12 to about 22 carbon atoms With the predominant 
chain lengths being from about 16 to about 22 carbon atoms, 
although both longer and shorter chain lengths are knoWn in 
the art. The structure of a fatty acid is represented herein by a 
notation system of “X:Y”, Where X is the total number of 
carbon (C) atoms and Y is the number of double bonds. 
Typically, fatty acids are classi?ed as either saturated or 
unsaturated fatty acids. 
The term “saturated fatty acids” refers to those fatty acids 
that have no double bonds betWeen the carbon atoms in their 
backbone. In contrast, “unsaturated fatty acids” are cis-iso 
mers that have double bonds along their carbon backbones. 
“Monounsaturated fatty acids” have only one double bond 
along the carbon backbone (e.g., betWeen the 9th and 10th 
carbon atom forpalmitoleic acid (16:1) and oleic acid (1 8: 1)), 
While “polyunsaturated fatty acids” have at least tWo double 
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bonds along their carbon backbone (e.g., between the 9th and 
10th, and 12th and 13th carbon atoms for linoleic acid (18:2); 
and betWeen the 9th and 10th, 12th and 13th, and 15th and 
16th carbons atoms for ot-linoleic acid (18:3)). 
The term “desaturase” is used herein to refer to a polypep 
tide capable of catalyzing the desaturation (i.e. the introduc 
tion of a double bond) of one or more fatty acids to produce an 
unsaturated fatty acid of interest. For example, a A9 desatu 
rase catalyZes the conversion of palmitic acid (16:0) to palmi 
toleic acid (16:1) and/or stearic acid (18:0) to oleic acid 
(18:1). In this regard, a desaturase can be said to be “active 
Wit ” a fatty acid, the desaturation of Which it catalyZes. For 
example, a A9 desaturase can be said to be active With palm 
itic acid (16:0) and stearic acid (18:0) because it can catalyZe 
the conversion of palmitic acid (16:0) to palmitoleic acid 
(16:1) and/or stearic acid (18:0) to oleic acid (18: 1). 
Examples of other desaturases include, but are not limited to, 
A8 desaturases that catalyZe the conversion of eicosadienoic 
acid (20:2) to dihomo-y-linoleic acid (20:3) and/or eicosa 
trienoic acid (20:3) to eicosatetraenoic acid (20:4), A5 desatu 
rases that catalyZe the conversion of dihomo-y-linoleic acid 
(20:3) to arachidonic acid (20:4) and/or eicosatetraenoic acid 
(20:4) to eicosapentanoic acid (20:5), A6 desaturases that 
catalyZe the conversion of linoleic acid (18:2) to y-linoleic 
acid (18:3) and/or ot-linoleic acid (18:3) to stearidonic acid 
(18:4), A4 desaturases that catalyZe the conversion of docosa 
pentanoic acid (22:5) to docosahexanoic acid (22:6), A12 
desaturases that catalyZe the conversion of oleic acid (1 8: 1) to 
linoleic acid (18:2); A15 desaturases that catalyZe the conver 
sion of linoleic acid (18:2) to ot-linoleic acid and/or y-linoleic 
acid (18:3) to stearidonic acid (18:4), and A17 desaturases 
that catalyze the conversion of arachidonic acid (20:4) to 
eicosapentanoic acid by introducing a double bond betWeen 
the C17 and C18 carbon atoms. 
In animal and fungal cells, monounsaturated fatty acids are 
aerobically synthesiZed from saturated fatty acids by 
microsomal membrane-bound A9 fatty acid desaturases (1). 
The desaturation pathWay starts by the introduction of a 
double bond betWeen C9 and CIO of stearoyl-ACP (in plants) 
or stearoyl-CoA (in fungi and animals), producing oleoyl 
thioesters (2). Most desaturases are endoplasmic reticulum 
(ER) membrane-bound diiron-oxo proteins and examination 
of deduced amino acid sequences for the membrane desatu 
rases from mammals, fungi, insects, higher plants, and cyano 
bacteria has revealed three regions of conserved primary 
sequence containing eight histidine residues. The conserved 
histidine residues are important for coordinating tWo iron 
atoms at the active site of the desaturase on the cytosolic face 
of the ER, While hydrophobic residues form tWo membrane 
spanning domains that anchor the protein in the lipid bilayer 
(3). Cytochrome b5 is used as the electron donor and in the 
majority of cases the desaturase is a protein fusion With a 
cytochrome b5 domain fused either at the N- or C-terminus 
(4). 
A9 desaturase genes have been isolated from a number of 
organisms including Trypanosoma brucei, Hansenula poly 
morphs, Morlierella alpina, Cryplococcus curvalus, 
Lenlinula edodes, Caenorhabdilis elegans, Drosophila, and 
mice. Although fatty acid desaturation Was ?rst described 
using a yeast A9 desaturase system, only animal A9 enZymes 
have been successfully puri?ed to homogeneity (5, 6). Fur 
ther, expression of A9 desaturase is highly regulated in several 
organisms, including Saccharomyces cerevisiae, and this 
control is exerted both at the transcriptional and post-tran 
scriptional level (7, 8). The A9 desaturase genes of M alpina 
(4), R angusla and I’. lipolylica (9) also shoW transcriptional 
regulation in response to supplementation With A9-unsatur 
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ated fatty acids although no such repression has been 
observed for K. lhermololerance or for S. kluveri (10). Simi 
larly fatty acid analysis has shoWn that the ratio of palmitoleic 
acid to oleic acid Was loWer in S. kluveri (10) and M alpina 
(4). 
Despite the numerous reports regarding A9 desaturase 
genes, hoWever, very feW A9 desaturase proteins have been 
reported to have palmitic acid (16:0) speci?city, much less 
speci?city With both palmitic acid and stearic acid (18:0). For 
example, of the three C. elegans open reading frames that 
display A9 desaturase activity, only one of them readily 
desaturates palmitic acid, and the activity of this protein With 
stearic acid as a substrate has been reported to be very loW (3). 
Further, of the fungal A9 desaturases reported thus far, the 
Saccharomyces cerevisiae A9 desaturase is the only enZyme 
that prefers palmitic acid as substrate. 
Thus, there is presently an unmet need for fungal desatu 
rases that are active With both palmitic acid and stearic acid 
substrates. Disclosed herein are nucleic acid and amino acid 
sequences for mushroom desaturase polypeptides that exhibit 
activity With both palmitic acid and stearic acid substrates. As 
disclosed herein in the Examples, it Was ascertained that these 
novel sequences encoding mushroom desaturases canbe used 
to transform plant cells and provide a method to increase the 
production of monounsaturated fatty acids Within the plant 
cells. Accordingly, the presently-disclosed subject matter 
includes mushroom desaturase nucleic acid and amino acid 
sequences, as Well as methods of using the same to produce 
monounsaturated fatty acids, such as palmitoleic acid and 
oleic acid. 
In some embodiments of the presently-disclosed subject 
matter, an isolated nucleic acid is provided. In some embodi 
ments, the isolated nucleic acid comprises a sequence encod 
ing a mushroom desaturase polypeptide, or a functional frag 
ment or functional variant thereof, that is active With palmitic 
acid and stearic acid. In some embodiments, an isolated 
nucleic acid is provided that comprises the sequence of SEQ 
ID NO: 1 or a degenerate variant of SEQ ID NO: 1. In some 
embodiments, and isolated nucleic acid is provided that com 
prises the sequence of SEQ ID NO: 2 or a degenerate variant 
of SEQ ID NO: 2. 
The term “gene” is used broadly to refer to any segment of 
DNA associated With a biological function. Thus, genes 
include, but are not limited to, coding sequences and/or the 
regulatory sequences required for their expression. Genes can 
also include non-expressed DNA segments that, for example, 
form recognition sequences for a polypeptide. Genes can be 
obtained from a variety of sources, including cloning from a 
source of interest or synthesiZing from knoWn or predicted 
sequence information, and can include sequences designed to 
have desired parameters. 
The term “nucleic acid” refers to deoxyribonucleotides or 
ribonucleotides and polymers thereof in either single- or 
double-stranded form. Unless speci?cally limited, the term 
encompasses nucleic acids containing knoWn analogues of 
natural nucleotides that have similar binding properties as the 
reference nucleic acid and are metaboliZed in a manner simi 
lar to naturally-occurring nucleotides. Unless otherWise indi 
cated, a particular nucleic acid sequence also implicitly 
encompasses conservatively modi?ed variants thereof (e.g., 
degenerate codon substitutions) and complementary 
sequences and as Well as the sequence explicitly indicated. 
The term “isolated”, Whenused in the context of an isolated 
nucleic acid molecule or an isolated polypeptide, is a nucleic 
acid molecule or polypeptide that, by the hand of man, exists 
apart from its native environment and is therefore not a prod 
uct of nature. An isolated nucleic acid molecule or polypep 
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tide can exist in a puri?ed form or can exist in a non-native 
environment such as, for example, in a transgenic host cell. 
The term “degenerate variant” refers to a nucleic acid hav 
ing a residue sequence that differs from a reference nucleic 
acid by one or more degenerate codon substitutions. Degen 
erate codon substitutions can be achieved by generating 
sequences in Which the third position of one or more selected 
(or all) codons is substituted With mixed base and/or deoxyino 
sine residues (BatZer et al. (1991) Nucleic Acid Res 19:5081; 
Ohtsuka et al. (1985) JBiol Chem 26012605 2608; Rossolini 
et al. (1994) Mol Cell Probes 8:91 98). 
In some embodiments of the presently-disclosed subject 
matter, an isolated nucleic acid is provided that encodes an 
amino acid sequence of SEQ ID NO: 3 or a functional frag 
ment or a functional variant of SEQ ID NO: 3. In some 
embodiments, an isolated nucleic acid is provided that 
encodes an amino acid sequence of SEQ ID NO: 4 or a 
functional fragment or a functional variant of SEQ ID NO: 4. 
The terms “polypeptide”, “protein”, and “peptide”, Which 
are used interchangeably herein, refer to a polymer of the 20 
protein amino acids, or amino acid analogs, regardless of its 
siZe or function. Although “protein” is often used in reference 
to relatively large polypeptides, and “peptide” is often used in 
reference to small polypeptides, usage of these terms in the art 
overlaps and varies. The term “polypeptide” as used herein 
refers to peptides, polypeptides, and proteins, unless other 
Wise noted. The terms “protein”, “polypeptide” and “peptide” 
are used interchangeably herein When referring to a gene 
product. Thus, exemplary polypeptides include gene prod 
ucts, naturally occurring proteins, homologs, orthologs, para 
logs, fragments and other equivalents, variants, and analogs 
of the foregoing. 
The terms “polypeptide fragment” or “fragment”, When 
used in reference to a reference polypeptide, refers to a 
polypeptide in Which amino acid residues are deleted as com 
pared to the reference polypeptide itself, but Where the 
remaining amino acid sequence is usually identical to the 
corresponding positions in the reference polypeptide. Such 
deletions can occur at the amino-terminus or carboxy-termi 
nus of the reference polypeptide, or alternatively both. Frag 
ments typically are at least 10, 20, 30, 40, 50, 60, 70, 80, 90, 
100, 120, 140, 160, 180 200, 210, or 220 amino acids long. 
A fragment can also be a “functional fragment,” in Which 
case the fragment retains some or all of the activity of the 
reference polypeptide as described herein. For example, in 
some embodiments, a functional fragment of a mushroom 
desaturase polypeptide retains some or all of the ability of the 
reference polypeptide to desaturate a saturated fatty acid. As 
noted herein above and in FIG. 2, an exemplary mushroom 
desaturase polypeptide of the presently-disclosed subject 
matter can be described as being comprised of discrete 
domains including a desaturase domain and a cytochrome b5 
domain. As such, in some embodiments, a functional frag 
ment of a mushroom desaturase polypeptide can be a peptide 
that comprises the desaturase domain or a peptide that com 
prises a cytochrome b5 domain. As one exemplary embodi 
ment of functional fragment of a mushroom desaturase 
polypeptide disclosed herein, the functional fragment of a 
mushroom desaturase polypeptide can be a polypeptide com 
prised of the desaturase domain, such as the polypeptide of 
SEQ ID NO: 4. 
As noted above, fungal desaturase polypeptides of the 
presently-disclosed subject matter include mushroom desatu 
rase polypeptides, Which can comprise or consist essentially 
of a functional fragment of mushroom desaturase protein. A 
fragment can be identi?ed With reference to amino acid resi 
dues in a reference polypeptide. For example, in some 
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embodiments, a fragment can comprise or consist essentially 
of amino acids 90-310 of a full-length mushroom desaturase 
polypeptide, such as the polypeptide set forth in SEQ ID NO: 
3. Such a fragment can be referred to as mushroom desaturase 
90-310 or a 90-310 fragment. 
In some embodiments, a polypeptide is provided that com 
prises a mushroom desaturase polypeptide comprising a frag 
ment. In some embodiments, the fragment can begin at (i.e. 
extend from) about amino acid 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 
12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23,24, 25, 26, 27, 28, 
29, 30,31, 32, 33, 34, 35,36, 37, 38, 39, 40,41, 42, 43, 44, 45, 
46, 47, 48, 49, 50, 51, 52, 52, 54, 55, 56, 57, 58, 59, 60, 61, 62, 
63, 64, 65, 66, 67, 68, 69,70, 71, 72, 73, 74,75, 76, 77, 78, 79, 
80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 
97, 98, 99, or 100 of a full-length mushroom desaturase 
polypeptide, such as the polypeptide set forth in SEQ ID NO: 
3. In some embodiments, the functional fragment can end at 
(i.e., extend to) about amino acid 350, 349, 348, 347, 346, 
345, 344, 343, 342, 341, 340, 339, 338, 337, 336, 335, 334, 
333, 332, 331, 330, 329, 328, 327, 326, 325, 324, 323, 322, 
321, 320, 319, 318, 317, 316, 315, 314, 313, 312, 311, 310, 
309, 308, 307, 306, 305, 304, 303, 302, 301, or 300 of a 
full-length mushroom desaturase polypeptide, such as the 
polypeptide set forth in SEQ ID NO: 3. 
In some embodiments, the fragment begins at (i.e., extends 
from) about amino acid 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 
14, 15, 16, 17, 18, 19, 20,21, 22, 23, 24, 25,26, 27, 28, 29, 30, 
31, 32,33, 34, 35, 36, 37,38, 39, 40, 41, 42,43, 44, 45, 46, 47, 
48,49,50, 51, 52, 52, 54,55, 56, 57, 58, 59,60, 61, 62, 63, 64, 
65, 66, 67, 68, 69, 70, 71,72, 73, 74, 75, 76,77, 78, 79, 80, 81, 
82, 83,84, 85, 86, 87, 88,89, 90, 91, 92, 93,94, 95, 96, 97, 98, 
99, or 100; and ends at (i.e., extends to) about amino acid 350, 
349, 348,347, 346, 345,344, 343, 342,341,340, 339,338, 
337, 336,335, 334, 333,332, 331, 330,329,328, 327,326, 
325, 324,323, 322, 321,320, 319, 318,317,316, 315,314, 
313, 312,311, 310, 309,308, 307, 306,305,304, 303,302, 
301, or 300 of a full-length mushroom desaturase polypep 
tide, such as the polypeptide set forth in SEQ ID NO: 3. In 
some embodiments, a mushroom desaturase polypeptide is 
provided that comprises or consists essentially of a mush 
room desaturase fragment selected from 90-310 (SEQ ID 
NO: 4) and 75-345. 
The terms “modi?ed amino acid”, “modi?ed polypeptide”, 
and “variant” refer to an amino acid sequence that is different 
from the reference polypeptide by one or more amino acids, 
e.g., one or more amino acid substitutions. A variant of a 
reference polypeptide also refers to a variant of a fragment of 
the reference polypeptide, for example, a fragment Wherein 
one or more amino acid substitutions have been made relative 
to the reference polypeptide. A variant can also be a “func 
tional variant,” in Which the variant retains some or all of the 
activity of the reference protein as described herein. For 
example, a functional variant of a mushroom desaturase 
polypeptide retains some or all of the ability of the reference 
polypeptide to desaturate a saturated fatty acid. 
The term functional variant includes a functional variant of 
a functional fragment of a reference polypeptide. The term 
functional variant further includes conservatively substituted 
variants. The term “conservatively substituted variant” refers 
to a peptide comprising an amino acid residue sequence that 
differs from a reference peptide by one or more conservative 
amino acid substitutions, and maintains some or all of the 
activity of the reference peptide as described herein. A “con 
servative amino acid substitution” is a substitution of an 
amino acid residue With a functionally similar residue. 
Examples of conservative substitutions include the substitu 
tion of one non-polar (hydrophobic) residue such as isoleu 
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cine, valine, leucine or methionine for another; the substitu 
tion of one charged or polar (hydrophilic) residue for another 
such as betWeen arginine and lysine, betWeen glutamine and 
asparagine, betWeen threonine and serine; the substitution of 
one basic residue such as lysine or arginine for another; or the 
substitution of one acidic residue, such as aspartic acid or 
glutamic acid for another; or the substitution of one aromatic 
residue, such as phenylalanine, tyrosine, or tryptophan for 
another. The phrase “conservatively substituted variant” also 
includes peptides Wherein a residue is replaced With a chemi 
cally derivatiZed residue, provided that the resulting peptide 
maintains some or all of the activity of the reference peptide 
as described herein. 
Further provided, in some embodiments of the presently 
disclosed subject matter, are isolated polypeptides. In some 
embodiments, an isolated polypeptide is provided that com 
prises a mushroom desaturase, or a functional fragment or a 
functional variant thereof, that is active With palmitic acid and 
stearic acid. In some embodiments, the polypeptide has an 
amino acid sequence of SEQ ID NO: 3 or SEQ ID NO: 4, or 
functional fragments or functional variants thereof. In some 
embodiments, the polypeptide is encoded by a nucleic acid 
that comprises a sequence of SEQ ID NO: 1 or that comprises 
a sequence of SEQ ID NO: 2 or degenerate variants thereof. 
In some embodiments, an isolated polypeptide is provided 
that is isolated from R oslrealus. The oyster mushroom, R 
oslrealus, is an edible basidomycete of high nutritional value 
due to the high levels of vitamins, proteins, and unsaturated 
fatty acids found Within the mushroom. R oslrealus is pro 
duced industrially for the manufacture of paper pulp, co smet 
ics, and pharmaceuticals. HoWever, the farming of oyster 
mushrooms is time and labor intensive, thus making the com 
mercial cultivation of oyster mushrooms as a source ofunsat 
urated fatty acids agronomically unfeasible. The inventors of 
the presently-disclosed subject matter have surprisingly dis 
covered though that desaturase genes from R oslrealus can be 
e?iciently and economically used to produce desaturase 
polypeptides that are capable of increasing the accumulation 
of monounsaturated fatty acids in plants that can be groWn on 
a commercial scale. As such, in some embodiments of the 
presently-disclosed subject matter, an isolated polypeptide is 
provided that is a P oslrealus A9 desaturase polypeptide. 
In some embodiments of the presently-disclosed subject 
matter, vectors that include one or more of the nucleic acid 
sequences disclosed herein are provided. In some embodi 
ments, vectors are provided that comprise an nucleic acid 
sequence that encodes a mushroom desaturase polypeptide, 
or a functional fragment or a functional variant thereof, that is 
active With palmitic acid and stearic acid. For example, in 
some embodiments, the vectors can be comprised of a nucleic 
acid sequence comprising the sequence of SEQ ID NO: 1 or 
SEQ ID NO: 2, or degenerate variants thereof. As another 
example, in some embodiments, the vectors canbe comprised 
of a nucleic acid sequence that encodes an amino acid 
sequence of SEQ ID NO: 3 or an amino acid sequence of SEQ 
ID NO: 4, or functional fragments or functional variants 
thereof. 
The term “vector” is used herein to refer to any vehicle that 
is capable of transferring a nucleic acid sequence into another 
cell. For example, vectors Which can be used in accordance 
With the presently-disclosed subject matter include, but are 
not limited to, plasmids, cosmids, bacteriophages, or viruses, 
Which can be transformed by the introduction of a nucleic 
acid sequence of the presently-disclosed subject matter. Such 
vectors are Well knoWn to those of ordinary skill in the art. As 
one exemplary embodiment of a vector comprising a nucleic 
acid sequence of the presently disclosed subject matter, an 
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exemplary vector can be a plasmid, such as the plasmid 
pCAMBIA 1301, into Which a nucleic acid encoding a mush 
room desaturase polypeptide can be cloned by the use of 
internal restriction sites present Within the vector. 
In some embodiments, the nucleic acids of the presently 
disclosed subject matter are operably linked to an expression 
cassette. The terms “associated Wit ”, “operably linked”, and 
“operatively linked” refer to tWo nucleic acid sequences that 
are related physically or functionally. For example, a pro 
moter or regulatory DNA sequence is said to be “associated 
With” a DNA sequence that encodes an RNA or a polypeptide 
if the tWo sequences are operatively linked, or situated such 
that the regulator DNA sequence Will affect the expression 
level of the coding or structural DNA sequence. 
The term “expression cassette” refers to a nucleic acid 
molecule capable of directing expression of a particular 
nucleotide sequence in an appropriate host cell, comprising a 
promoter operatively linked to the nucleotide sequence of 
interest Which is operatively linked to termination signals. It 
also typically comprises sequences required for proper trans 
lation of the nucleotide sequence. The coding region usually 
encodes a polypeptide of interest but can also encode a func 
tional RNA of interest, for example antisense RNA or a non 
translated RNA, in the sense or antisense direction. The 
expression cassette comprising the nucleotide sequence of 
interest can be chimeric, meaning that at least one of its 
components is heterologous With respect to at least one of its 
other components. The expression cassette can also be one 
that is naturally occurring but has been obtained in a recom 
binant form useful for heterologous expression. 
In some embodiments, an expression cassette is provided 
that comprises a “constitutive promoter,” such as a 35S pro 
moter, a ?gWort mosaic promoter, or the constitutive plant 
promoter of ubiquitin, that continually expresses a nucleic 
acid sequence of the presently-disclosed subject matter in all 
types of cells Where it is inserted. For some applications, it is 
useful to direct the expression of a nucleic acid sequence of 
the presently-disclosed subject matter to different tissues of a 
plant. As such, in some embodiments, an expression cassette 
is provided that comprises a “seed-speci?c promoter,” such as 
a phaseolin, glycinin, conglycinin, seed lectin, napin, 
cruferin, or other seed-speci?c promoter, that expresses a 
nucleic acid sequence of the presently-disclosed subject mat 
ter only in seeds of a desired plant. 
The presently-disclosed subject matter also provides trans 
genic plant cells or plants that comprise one or more of the 
nucleic acids disclosed herein. As used herein, the term “plant 
cell” is understood to mean any cell derived from a mono 
cotyledonous or a dicotyledonous plant and capable of con 
stituting undifferentiated tissues such as calli, differentiated 
tissues such as embryos, portions of monocotyledonous 
plants, monocotyledonous plants or seed. The term “plant” is 
understood to mean any differentiated multicellular organism 
capable of photosynthesis, including monocotyledons and 
dicotyledons. In some embodiments, the plant cell can be an 
Arabidopsis plant cell, a tobacco plant cell, a soybean plant 
cell, a petunia plant cell, or a cell from another oilseed crop 
including, but not limited to, a canola plant cell, a rapeseed 
plant cell, a palm plant cell, a sun?ower plant cell, a cotton 
plant cell, a corn plant cell, a peanut plant cell, a ?ax plant cell, 
and a sesame plant cell. 
The terms “transformed”, “transgenic”, and “recombi 
nant” refer to a cell of a host organism such as a plant into 
Which a heterologous nucleic acid molecule has been intro 
duced. The nucleic acidmolecule canbe stably integrated into 
the genome of the cell, or the nucleic acid molecule can be 
present as an extrachromosomal molecule. Such an extrach 
US 8,053,633 B1 
13 
romosomal molecule can be auto-replicating. Transformed 
cells, tissues, or subjects are understood to encompass not 
only the end product of a transformation process, but also 
transgenic progeny thereof. 
The terms “heterologous”, “recombinant”, and “exog 
enous”, When used herein to refer to a nucleic acid sequence 
(eg a DNA sequence) or a gene, refer to a sequence that 
originates from a source foreign to the particular host cell or, 
if from the same source, is modi?ed from its original form. 
Thus, a heterologous gene in a host cell includes a gene that is 
endogenous to the particular host cell but has been modi?ed 
through, for example, the use of site-directed mutagenesis or 
other recombinant techniques. The terms also include non 
naturally occurring multiple copies of a naturally occurring 
DNA sequence. Thus, the terms refer to a DNA segment that 
is foreign or heterologous to the cell, or homologous to the 
cell but in a position or form Within the host cell in Which the 
element is not ordinarily found. Similarly, When used in the 
context of a polypeptide or amino acid sequence, an exog 
enous polypeptide or amino acid sequence is a polypeptide or 
amino acid sequence that originates from a source foreign to 
the particular host cell or, if from the same source, is modi?ed 
from its original form. Thus, exogenous DNA segments can 
be expressed to yield exogenous polypeptides. 
Introduction of a nucleic acid of the presently-disclosed 
subject matter into a plant cell can be performed by a variety 
of methods knoWn to those of ordinary skill in the art includ 
ing, but not limited to, insertion of a nucleic acid sequence of 
interest into an Agrobaclerium rhizogenes Ri or Agrobacle 
rium Zumefaciens Ti plasmid, microinj ection, electropora 
tion, or direct precipitation. By Way of providing another 
example, in some embodiments, transient expression of a 
nucleic acid sequence or gene of interest can be performed by 
agroin?ltration methods. In this regard, a suspension of A gro 
bacterium Zumefaciens containing a gene of interest can be 
groWn in culture and then injected into a plant by placing the 
tip of a syringe against the underside of a leaf While gentle 
counter-pressure is applied to the other side of the leaf. The 
Agrobaclerium solution is then injected into the airspaces 
inside the leaf through stomata. Once inside the leaf, the 
A grobaclerium transforms the gene of interest to a portion of 
the plant cells Where the gene is then transiently expressed. 
As another example, transformation of a plasmid or nucleic 
acid of interest into a plant cell can be performed by particle 
gun bombardment techniques. In this regard, a suspension of 
plant embryos can be groWn in liquid culture and then bom 
barded Withplasmids or nucleic acids that are attached to gold 
particles, Wherein the gold particles bound to the plasmid or 
nucleic acid of interest can be propelled through the mem 
branes of the plant tissues, such as embryonic tissue. FolloW 
ing bombardment, the transformed embryos can then be 
selected using an appropriate antibiotic to generate neW, 
clonally propagated, transformed embryogenic suspension 
cultures. 
For additional guidance regarding methods of transform 
ing and producing transgenic plant cells, see US. Pat. Nos. 
4,459,355; 4,536,475; 5,464,763; 5,177,010; 5,187,073; 
4,945,050; 5,036,006; 5,100,792; 5,371,014; 5,478,744; 
5,179,022; 5,565,346; 5,484,956; 5,508,468; 5,538,877; 
5,554,798; 5,489,520; 5,510,318; 5,204,253; 5,405,765; EP 
Nos. 267,159; 604,662; 672,752; 442,174; 486,233; 486,234; 
539,563; 674,725; and, International Patent Application Pub 
lication Nos. WO 91/02071 and WO 95/06128, each ofWhich 
is incorporated herein by this reference. 
Still further provided, in some embodiments of the pres 
ently-disclosed subject matter, are methods of producing a 
monounsaturated fatty acid. In some embodiments, the 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
14 
method comprises: transforming a cell With a nucleic acid 
encoding a mushroom desaturase polypeptide, or a functional 
fragment or functional variant thereof, that is active With 
palmitic acid and stearic acid; expressing the desaturase 
polypeptide to thereby increase the amount of a the monoun 
saturated fatty acid in the cell; and, extracting an oil contain 
ing the increased amount of the monounsaturated fatty acid 
from the cell. In some embodiments, the monounsaturated 
fatty acid is palmitoleic acid or oleic acid. 
The “amount” of a monounsaturated fatty acid in a cell can 
be determined by methods knoWn to those of ordinary skill in 
the art. For example, gas chromatography-mass spectrometry 
or gas chromatography can be utiliZed to determine a total 
amount of monounsaturated fatty acids in a sample obtained 
from a cell transformed With a nucleic acid of the presently 
disclosed subject matter. An increase in the amount of a 
monounsaturated fatty acid can then be measured relative to a 
control level of the monounsaturated fatty acid. The “control 
level” is an amount or range of amounts of the monounsat 
urated fatty acid found in a comparable samples in cells that 
have not been transformed With a nucleic acid of the pres 
ently-disclosed subject matter. In some embodiments, the 
increase in the amounts of the monounsaturated fatty acid can 
be about 1%, about 5%, about 8%, about 10%, about 15%, 
about 20%, about 25%, about 30%, about 40%, about 45%, or 
about 50%. 
In some embodiments of the methods for producing a 
monounsaturated fatty acid, a cell is transformed With a 
nucleic acid of the presently-disclosed subject matter that is 
capable of expressing a polypeptide that is encoded by SEQ 
ID NO: 1 or SEQ ID NO: 2, or degenerate variants thereof. In 
some embodiments, the polypeptide is encoded by a nucleic 
acid sequence that encodes an amino acid sequence of SEQ 
ID NO: 3 or SEQ ID NO: 4, or functional fragments or 
functional variants thereof. 
The methods of producing a monounsaturated fatty acid 
disclosed herein can be used to provide a monounsaturated 
fatty acid that can further be used in various food products or 
for industrial applications. As such, in some embodiments of 
the presently-disclosed subject matter a monounsaturated 
fatty acid is provided, such as a palmitoleic acid or an oleic 
acid. 
In some embodiments, a monounsaturated fatty acid is 
provided that is prepared by a process that comprises: trans 
forming a cell With a nucleic acid of the presently-disclosed 
subject matter encoding a fungal desaturase polypeptide, or 
functional fragment or functional variant thereof, that is 
active With palmitic acid and stearic acid; expressing the 
desaturase polypeptide to increase an amount of a monoun 
saturated fatty acid in a cell; and, extracting an oil containing 
the increased amount of the monounsaturated fatty acid from 
the cell. Extraction of an oil from a cell can be performed by 
a variety of methods knoWn to those of ordinary skill in the 
art. For example, an oil containing an increased amount of a 
monounsaturated fatty acid can be extracted from a plant cell 
using a common solvent extraction or, alternatively, an oil 
containing an increased amount of a monounsaturated fatty 
acid can be extracted from a plant cell by pressing the oil out 
of plant cells and/or tissues and then collecting the oil in a 
suitable container. 
The practice of the presently-disclosed subject matter can 
employ, unless otherWise indicated, conventional techniques 
of cell biology, cell culture, molecular biology, transgenic 
biology, microbiology, recombinant DNA, and immunology, 
Which are Within the skill of the art. Such techniques are 
explained fully in the literature. See e.g., Molecular Cloning 
A Laboratory Manual (1989), 2nd Ed., ed. by Sambrook, 






















